BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2017195)

  • 1. Structural and functional analysis of the S1 subunit of pertussis toxin using synthetic peptides.
    Chong P; Sydor M; Wu E; Zobrist G; Boux H; Klein M
    Mol Immunol; 1991 Mar; 28(3):239-45. PubMed ID: 2017195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of T- and B-cell epitopes of the S2 and S3 subunits of pertussis toxin by use of synthetic peptides.
    Chong P; Zobrist G; Sia C; Loosmore S; Klein M
    Infect Immun; 1992 Nov; 60(11):4640-7. PubMed ID: 1383153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective immunogenicity of synthetic peptides selected from the amino acid sequence of Bordetella pertussis toxin subunit S1.
    Askelöf P; Rodmalm K; Wrangsell G; Larsson U; Svenson SB; Cowell JL; Undén A; Bartfai T
    Dev Biol Stand; 1991; 73():111-20. PubMed ID: 1778305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective immunogenicity of two synthetic peptides selected from the amino acid sequence of Bordetella pertussis toxin subunit S1.
    Askelöf P; Rodmalm K; Wrangsell G; Larsson U; Svenson SB; Cowell JL; Undén A; Bartfai T
    Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1347-51. PubMed ID: 2304902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epitopes on the S1 subunit of pertussis toxin recognized by monoclonal antibodies.
    Kim KJ; Burnette WN; Sublett RD; Manclark CR; Kenimer JG
    Infect Immun; 1989 Mar; 57(3):944-50. PubMed ID: 2465274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of pertussis toxin analogs containing mutations in B-oligomer subunits.
    Loosmore S; Zealey G; Cockle S; Boux H; Chong P; Yacoob R; Klein M
    Infect Immun; 1993 Jun; 61(6):2316-24. PubMed ID: 8500874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between structure and biological and protective activities of pertussis toxin.
    Sato H; Sato Y
    Dev Biol Stand; 1991; 73():121-32. PubMed ID: 1723387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A quantitative analysis for the ADP-ribosylation activity of pertussis toxin: an enzymatic-HPLC coupled assay applicable to formulated whole cell and acellular pertussis vaccine products.
    Cyr T; Menzies AJ; Calver J; Whitehouse LW
    Biologicals; 2001 Jun; 29(2):81-95. PubMed ID: 11580213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple T and B cell epitopes in the S1 subunit ("A"-monomer) of the pertussis toxin molecule.
    Oksenberg JR; Ko C; Judd AK; Lim M; Kent A; Schoolnik GK; Steinman L
    J Immunol; 1989 Dec; 143(12):4227-31. PubMed ID: 2480389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elucidation of linear epitopes of pertussis toxin using overlapping synthetic decapeptides: identification of a human B-cell determinant in the S1 subunit indicative of acute infections.
    Raupach B; Schmidt MA
    Microb Pathog; 1994 Oct; 17(4):213-26. PubMed ID: 7536288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recognition of pertussis toxin by antibodies to synthetic peptides.
    Seabrook RN; Robinson A; Sharma RP; Irons LI; Ashworth LA; Price CP; Atkinson T
    Mol Immunol; 1990 Aug; 27(8):777-85. PubMed ID: 2402246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assignment of functional domains involved in ADP-ribosylation and B-oligomer binding within the carboxyl terminus of the S1 subunit of pertussis toxin.
    Krueger KM; Barbieri JT
    Infect Immun; 1994 May; 62(5):2071-8. PubMed ID: 8168972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of B-cell epitopes on the S4 subunit of pertussis toxin.
    Ibsen PH; Holm A; Petersen JW; Olsen CE; Heron I
    Infect Immun; 1993 Jun; 61(6):2408-18. PubMed ID: 7684728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human T cell clones define S1 subunit as the most immunogenic moiety of pertussis toxin and determine its epitope map.
    De Magistris MT; Romano M; Bartoloni A; Rappuoli R; Tagliabue A
    J Exp Med; 1989 May; 169(5):1519-32. PubMed ID: 2469760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and characterization of Pertussis toxin subunits.
    Sheu GC; Wo YY; Lu CH
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1997 Aug; 30(3):182-93. PubMed ID: 10592823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADP-ribosylation of alpha i3C20 by the S1 subunit and deletion peptides of S1 of pertussis toxin.
    Finck-Barbançon V; Barbieri JT
    Biochemistry; 1995 Jan; 34(3):1070-5. PubMed ID: 7827022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of a region of the S1 subunit of pertussis toxin required for efficient ADP-ribosyltransferase activity.
    Cortina G; Barbieri JT
    J Biol Chem; 1991 Feb; 266(5):3022-30. PubMed ID: 1993675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of linear B-cell determinants of pertussis toxin associated with the receptor recognition site of the S3 subunit.
    Schmidt MA; Raupach B; Szulczynski M; Marzillier J
    Infect Immun; 1991 Apr; 59(4):1402-8. PubMed ID: 1706321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of polyclonal antibodies to the S1 subunit of pertussis toxin by synthetic peptides coupled to PPD: effect of conjugation method, adjuvant, priming and animal species.
    Ibsen PH; Holm A; Raaschou-Nielsen M; Petersen JW; Capiau C; Heron I
    APMIS; 1992 Feb; 100(2):159-69. PubMed ID: 1554491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pertussis toxin S1 mutant with reduced enzyme activity and a conserved protective epitope.
    Burnette WN; Cieplak W; Mar VL; Kaljot KT; Sato H; Keith JM
    Science; 1988 Oct; 242(4875):72-4. PubMed ID: 2459776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.